Please login to the form below

IBD Registry appoints first CEO

The IBD Registry Board is delighted to announce the appointment of Liz Dobson as the first Chief Executive Officer of IBD Registry Ltd from 16th April 2018.  

The IBD Registry is familiar to many as the first UK-wide collection of anonymised adult and paediatric IBD data for prospective audit and research. The British Society of Gastroenterology (BSG), The Royal College of Physicians (RCP), and Crohn’s and Colitis UK joined forces at the end in 2017 to launch IBD Registry Ltd – an independent not-for-profit company and a new legal entity that positions the Registry for future growth. Liz will be the first Chief Executive of the new organisation.
 

Liz brings to the IBD Registry 20 years of executive and senior management experience from the private and not-for-profit sector, including early stage businesses. She brings both the leadership and business skills that the IBD Registry needs as a new non-profit company, combined with a robust background in operations, and technical understanding that will be of huge benefit to the Registry as it embarks on this next stage of its growth.  Liz's experience is underpinned by a Sloan Fellow MSc (Business) from London Business School, and BSc (Maths) first class honours.
 

She commented: “I’m delighted to be appointed as the Registry’s first CEO at this exciting and crucial stage of its development. My aim is to help the team to build on their considerable success to date for the benefit of all our stakeholders. I’m especially keen to develop enhanced ways of supporting clinical teams to gather and harness data that can be used effectively to develop better services and deliver better outcomes for IBD patients. I look forward to working with you all to realise the very bright future I believe we can create together for the Registry.”  

Amanda Quincey, current Chair* of the IBD Registry Board commented, “the Board are delighted to welcome Liz Dobson to the team. She joins us with excellent experience and shares our ambitions for an exciting future for the Registry.  We have recently faced some challenging times as we have been transitioning into our new form, and we thank all our stakeholders, especially clinical teams, for their continued support and patience during that period.”
 

IBD Registry Ltd is an independent not-for-profit company limited by guarantee, set up by the British Society of Gastroenterology (BSG), The Royal College of Physicians (RCP), and Crohn’s and Colitis UK in order to position the Registry for future growth. For more information, please contact support@ibdregistry.org.uk  

Image result for internet image  www.ibdregistry.org.uk

Image result for twitter@IBDRegistry 

*The role of chair of the Board will rotate every six months



13th April 2018

Share

Company Details

Dovetail

020 3176 6435

Contact Website

Address:
Vox Studios
1-45 Durham Street
London
SE11 5JH
United Kingdom

Latest content on this profile

IBD Registry appoints first CEO

Dovetail
Impact of data sharing
With the General Data Protection Regulation (GDPR) on the horizon, the Cambridge Analytica scandal has provided a stark reminder of the importance of data protection laws.
Dovetail
Value proposition development
Pharma companies need to demonstrate value to the NHS, so developing a clear statement to articulate that value to customers is a vital element of the marketing mix.
Dovetail
Joined-up thinking on anaemia
Iron deficiency anaemia is very common in inflammatory bowel disease (IBD) and can seriously reduce people’s quality of life, but it’s often under-treated.
Dovetail
Pharma and NHS working together for patients - the IBD Registry Industry Working Group
We hear a lot from pharma about patient-centricity these days, and rightly so. But there are many ways of putting this important principle into practice, and they don’t have to be complicated or expensive.
Dovetail